Beyond JAK-2: potential targets for myeloproliferative neoplasm therapy

Related Experiment Video

Updated: Feb 13, 2026

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

12.5K

Patrick M Harrington1, Claire N Harrison1

  • 1a Department of Haematology , Guys and St Thomas' NHS Foundation Trust , London , UK.

Expert Review of Hematology
|March 9, 2018
PubMed
Abstract

Insights

Recent advances in myeloproliferative neoplasms (MPN) treatment offer hope, but current therapies for myelofibrosis remain inadequate. Further research is crucial for disease modification and improved patient outcomes.

Area of Science:

  • Hematology
  • Oncology
  • Pharmacology

Background:

  • Myeloproliferative neoplasms (MPN), especially myelofibrosis, have seen improved patient outlooks due to better understanding of disease mechanisms.
  • Numerous novel therapeutic agents are emerging, driven by molecular pathogenesis discoveries.

Purpose of the Study:

  • To review recent advancements in MPN treatment.
  • To explore promising emerging agents and their potential.
  • To identify gaps in current therapeutic strategies.

Main Methods:

  • Extensive literature review of clinical trials and pre-clinical work.
  • Analysis of molecular pathogenesis discoveries.
  • Evaluation of diagnostic, prognostic, and treatment strategy advancements.

Main Results:

  • Molecular insights have advanced diagnostics, prognosis, and treatment strategies for MPN.
  • Current therapeutic options are insufficient for addressing key challenges like lifespan normalization and quality of life.
  • Early-phase clinical trials have yielded disappointing results, with limited disease-modifying activity and toxicity concerns.

Conclusions:

  • Despite progress, significant challenges remain in MPN management, particularly for myelofibrosis.
  • There is a critical need for effective disease-modifying therapies.
  • Future research must focus on developing treatments with meaningful biological endpoints and improved safety profiles.
Keywords:
JAK-inhibitorsMPNessential thrombocythemiamyelofibrosispolycythemia vera

More Related Videos

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K
Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats05:09

Lumbar Intrathecal Injection of Gene Therapy Vectors for Central Nervous System Targeting in Mice and Rats

Published on: May 16, 2025

3.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
12.7K
Standard Electrode Potentials03:02

Standard Electrode Potentials

On comparing the reactivity of silver and lead, it is observed that the two ionic species, Ag+ (aq) and Pb2+ (aq), show a difference in their redox reactivity towards copper: the silver ion undergoes spontaneous reduction, while the lead ion does not. This relative redox activity can be easily quantified in electrochemical cells by a property called cell potential. This property is commonly known as cell voltage in electrochemistry, and it is a measure of the energy which accompanies the charge...
50.5K
Cell Potential and Free Energy02:58

Cell Potential and Free Energy

Thermodynamics of a Redox Reaction
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...
46.8K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Potential Energy00:52

Potential Energy

The energy stored by a structure and location of matter in space is called potential energy. For instance, raising a kettlebell changes its spatial location and increases its potential energy. Similarly, a stretched rubber band contains potential energy which, under certain conditions, can be converted into other forms of energy, such as kinetic energy.
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
42.9K